Search

Search Constraints

You searched for: Subject EVIDENCE/GUIDELINES -- HEALTH SERVICES -- ECONOMICS -- OSTEOPOROSIS -- BISPHOSPHONATES -- AGING

Search Results

1. Cost‐effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. (15th January 2013)